Last reviewed · How we verify

Activase — Competitive Intelligence Brief

Activase (ALTEPLASE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Cardiovascular.

marketed Plasminogen Cardiovascular Enzyme Live · refreshed every 30 min

Target snapshot

Activase (ALTEPLASE) — Roche.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Activase TARGET ALTEPLASE Roche marketed Plasminogen 1996-01-01
Trasylol APROTININ Bayer marketed Antifibrinolytic Agent Plasminogen 1993-01-01
Cyklokapron TRANEXAMIC ACID Exela Pharma marketed Antifibrinolytic Agent [EPC] Plasminogen 1986-01-01
Amicar AMINOCAPROIC ACID Epic Pharma Llc marketed Antifibrinolytic Agent [EPC] Plasminogen 1964-01-01
rtPA rtPA Hui-Sheng Chen marketed Fibrinolytic agent; tissue plasminogen activator (tPA) Plasminogen; fibrin
Oral lumbrokinase DLBS1033 Oral lumbrokinase DLBS1033 Universitas Sebelas Maret marketed Fibrinolytic enzyme Fibrin; plasminogen activation pathway
Tranexamic Acid (IV) Tranexamic Acid (IV) Samsung Medical Center marketed Antifibrinolytic agent Plasminogen / Plasmin

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Activase — Competitive Intelligence Brief. https://druglandscape.com/ci/alteplase. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: